GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OncoSec Medical Inc (FRA:ONMA) » Definitions » Price-to-Funds-From-Operations

OncoSec Medical (FRA:ONMA) Price-to-Funds-From-Operations : (As of Oct. 31, 2024)


View and export this data going back to 2015. Start your Free Trial

What is OncoSec Medical Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


OncoSec Medical Business Description

Industry
Traded in Other Exchanges
N/A
Address
24 North Main Street, Pennington, NJ, USA, 08534
OncoSec Medical Inc is a healthcare sector company. It is focused on designing, developing and commercializing gene therapies, therapeutics, and medical approaches to stimulate an anti-tumor immune response for the treatment of cancer. The company's lead product candidate, ImmunoPulse IL-12, consists of a plasmid construct encoding the proinflammatory cytokine, IL-12, which is delivered into the tumor through in vivo electroporation. In addition, it is pursuing ImmunoPulse IL-12 monotherapy in patients with triple-negative breast cancer.